Meeting
2024 ASCO Annual Meeting
A deep learning–enabled workflow to estimate real world progression-free survival in patients with metastatic breast cancer.
Authors
Gowtham Varma
nference, Cambridge, MA
Gowtham Varma , Rohit Kumar Yenukoti , Praveen Kumar-M , Bandlamudi Sai Ashrit , K Purushotham , Subash C , Sunil Kumar Ravi , Verghese Kurien , Avinash Aman , Mithun Manoharan , Shashank Jaiswal , Akash Anand , Rakesh Barve , Viswanathan Thiagarajan , Patrick Lenehan , Scott A. Soefje , Venky Soundararajan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Quality Care/Health Services Research
Track
Care Delivery and Quality Care
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 11176)
DOI
10.1200/JCO.2024.42.16_suppl.11176
Abstract #
11176
Poster Bd #
371
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The role of natural language processing techniques versus conventional methods to gain ICI safety insights from unstructured EHR data.
First Author: Matthew Stephen Block
Poster
2023 ASCO Annual Meeting
Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale.
First Author: Smita Agrawal
Poster
2023 ASCO Annual Meeting
A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.
First Author: Fernanda Bronzon Damian
Poster
2022 ASCO Annual Meeting
Natural language processing of Veterans’ electronic health records to confirm diagnoses of monoclonal gammopathy of undetermined significance.
First Author: Mei Wang